ERBB2 and breast cancer: HER2+ BC is characterized by a high proportion of ALDH1+ epithelial BCSCs, but at a lower proportion than TNBC, followed by luminal B BC subtype displaying a certain proportion of BCSCs and luminal A BC exhibiting the lowest proportion of BCSCs [98].